Decreased factor XIII activity and haptoglobin may be markers of enhanced-fibrinolytic-type disseminated intravascular coagulation status: Case report.
{"title":"Decreased factor XIII activity and haptoglobin may be markers of enhanced-fibrinolytic-type disseminated intravascular coagulation status: Case report.","authors":"Shinya Yamada, Hideyasu Ueda, Yukio Suga, Toshihiro Miyamoto, Hidesaku Asakura","doi":"10.1097/MD.0000000000043123","DOIUrl":null,"url":null,"abstract":"<p><strong>Rationale: </strong>Aortic aneurysms are often accompanied by enhanced-fibrinolytic-type disseminated intravascular coagulation (DIC), but markers to adequately assess DIC status remain lacking.</p><p><strong>Patient concerns: </strong>An 80-year-old man scheduled for thoracic endovascular aortic repair for aortic aneurysm was diagnosed with enhanced-fibrinolytic-type DIC. The concern was whether surgery could be safely performed in a state of enhanced-fibrinolytic-type DIC with a bleeding tendency.</p><p><strong>Interventions: </strong>He was treated with a combination of heparin and tranexamic acid.</p><p><strong>Outcomes: </strong>DIC was well controlled and the surgery was performed safely. However, DIC worsened again postoperatively. Since no severe bleeding symptoms were observed, no therapeutic intervention for DIC was performed postoperatively. During this period, coagulation tests including factor XIII activity and haptoglobin were followed over time to clarify the relevance of these markers.Factor XIII activity was decreased and haptoglobin was mildly decreased in DIC. Improvement of DIC led to normalization of both markers. Re-exacerbation of DIC led to decreased factor XIII activity and mildly decreased haptoglobin.</p><p><strong>Lessons: </strong>Factor XIII activity and haptoglobin appear to represent useful markers of DIC status.</p>","PeriodicalId":18549,"journal":{"name":"Medicine","volume":"104 30","pages":"e43123"},"PeriodicalIF":1.4000,"publicationDate":"2025-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12303462/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/MD.0000000000043123","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Rationale: Aortic aneurysms are often accompanied by enhanced-fibrinolytic-type disseminated intravascular coagulation (DIC), but markers to adequately assess DIC status remain lacking.
Patient concerns: An 80-year-old man scheduled for thoracic endovascular aortic repair for aortic aneurysm was diagnosed with enhanced-fibrinolytic-type DIC. The concern was whether surgery could be safely performed in a state of enhanced-fibrinolytic-type DIC with a bleeding tendency.
Interventions: He was treated with a combination of heparin and tranexamic acid.
Outcomes: DIC was well controlled and the surgery was performed safely. However, DIC worsened again postoperatively. Since no severe bleeding symptoms were observed, no therapeutic intervention for DIC was performed postoperatively. During this period, coagulation tests including factor XIII activity and haptoglobin were followed over time to clarify the relevance of these markers.Factor XIII activity was decreased and haptoglobin was mildly decreased in DIC. Improvement of DIC led to normalization of both markers. Re-exacerbation of DIC led to decreased factor XIII activity and mildly decreased haptoglobin.
Lessons: Factor XIII activity and haptoglobin appear to represent useful markers of DIC status.
期刊介绍:
Medicine is now a fully open access journal, providing authors with a distinctive new service offering continuous publication of original research across a broad spectrum of medical scientific disciplines and sub-specialties.
As an open access title, Medicine will continue to provide authors with an established, trusted platform for the publication of their work. To ensure the ongoing quality of Medicine’s content, the peer-review process will only accept content that is scientifically, technically and ethically sound, and in compliance with standard reporting guidelines.